Compounds > gadolinium dtpa
Page last updated: 2024-09-04

gadolinium dtpa and nintedanib

gadolinium dtpa has been researched along with nintedanib in 1 studies

Compound Research Comparison

Studies
(gadolinium dtpa)		Trials
(gadolinium dtpa)		Recent Studies (post-2010)
(gadolinium dtpa)		Studies
(nintedanib)		Trials
(nintedanib)		Recent Studies (post-2010) (nintedanib)
12,6546644,051846133801

Protein Interaction Comparison

ProteinTaxonomygadolinium dtpa (IC50)nintedanib (IC50)
Platelet-derived growth factor receptor betaMus musculus (house mouse)0.085
Tyrosine-protein kinase LckHomo sapiens (human)0.016
Tyrosine-protein kinase LynHomo sapiens (human)0.1483
Platelet-derived growth factor receptor betaHomo sapiens (human)0.0133
Fibroblast growth factor receptor 1Homo sapiens (human)0.068
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)0.1093
Platelet-derived growth factor receptor alphaHomo sapiens (human)0.017
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.0395
Fibroblast growth factor receptor 2Homo sapiens (human)0.037
Fibroblast growth factor receptor 4Homo sapiens (human)0.61
Fibroblast growth factor receptor 3Homo sapiens (human)0.108
Platelet-derived growth factor receptor alpha Mus musculus (house mouse)0.085
Vascular endothelial growth factor receptor 3Homo sapiens (human)0.0116
Vascular endothelial growth factor receptor 2Mus musculus (house mouse)0.013
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.009
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.026
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.0026
Maternal embryonic leucine zipper kinaseHomo sapiens (human)0.043

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collins, DJ; Koh, DM; Leach, MO; Miyazaki, K; Padhani, AR; Taylor, JN; Walker-Samuel, S1

Trials

1 trial(s) available for gadolinium dtpa and nintedanib

ArticleYear
Quantitative mapping of hepatic perfusion index using MR imaging: a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor.
    European radiology, 2008, Volume: 18, Issue:7

    Topics: Adult; Aged; Angiogenesis Inhibitors; Contrast Media; Female; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Indoles; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Reproducibility of Results; Statistics, Nonparametric; Treatment Outcome

2008